UT Health San Antonio MD Anderson (@uthealthsamda) 's Twitter Profile
UT Health San Antonio MD Anderson

@uthealthsamda

The mission of Mays Cancer Center, home to UT Health San Antonio MD Anderson, is to decrease the burden of cancer in San Antonio, South Texas and beyond.

ID: 335460050

linkhttp://cancer.uthscsa.edu calendar_today14-07-2011 18:28:54

3,3K Tweet

1,1K Followers

418 Following

UT Health San Antonio MD Anderson (@uthealthsamda) 's Twitter Profile Photo

Dr. Andrew Brenner joined FOX SA Focus on South Texas to talk about glioblastoma— signs, symptoms and emerging treatments. He shared updates on the ReSPECT-GBM clinical trial, which is showing promising results, with some patients living twice as long: bit.ly/3HwlQtx

Dr. Andrew Brenner joined <a href="/KABBFOX29/">FOX SA</a> Focus on South Texas to talk about glioblastoma— signs, symptoms and emerging treatments. He shared updates on the ReSPECT-GBM clinical trial, which is showing promising results, with some patients living twice as long: bit.ly/3HwlQtx
UT Health San Antonio MD Anderson (@uthealthsamda) 's Twitter Profile Photo

Our offices will be closed this Thursday, June 19, in observance of Juneteenth. We will have limited staff available for scheduled appointments only. Normal business hours will resume on Friday, June 20.

Our offices will be closed this Thursday, June 19, in observance of Juneteenth. We will have limited staff available for scheduled appointments only. Normal business hours will resume on Friday, June 20.
UT Health San Antonio MD Anderson (@uthealthsamda) 's Twitter Profile Photo

Don’t miss the opportunity to attend the 2025 San Antonio Liver Cancer Symposium! Check out Dr. Cervantez’s session on Survivorship: Living with Liver Cancer. CME, MOC and CNE can be earned. bit.ly/4jJhkFP

Don’t miss the opportunity to attend the 2025 San Antonio Liver Cancer Symposium!

Check out Dr. Cervantez’s session on Survivorship: Living with Liver Cancer.

CME, MOC and CNE can be earned. bit.ly/4jJhkFP
UT Health San Antonio MD Anderson (@uthealthsamda) 's Twitter Profile Photo

Promising news for recurrent glioblastoma: In the ReSPECT-GBM trial, rhenium (186Re) obisbemeda showed median OS of 17.4 months vs. 8.5 months historically. Dr. Andrew Brenner discussed these findings in a recent @CancerNetwork interview. Learn more: bit.ly/44myMtN

Promising news for recurrent glioblastoma: In the ReSPECT-GBM trial, rhenium (186Re) obisbemeda showed median OS of 17.4 months vs. 8.5 months historically.

Dr. Andrew Brenner discussed these findings in a recent @CancerNetwork interview.

Learn more: bit.ly/44myMtN
UT Health San Antonio Research (@uthsaresearch) 's Twitter Profile Photo

šŸ“¢ #MaysCancerCenter is seeking US-based adults with #bloodcancer and experiencing #sleep disturbance to participate in a remote study of an 8-week digital wellness intervention. More here: cancer.uthscsa.edu/heme-study #leukemia #lymphoma #myeloma Mays Cancer Center at UT Health San Antonio The University of Texas System

UT Health San Antonio MD Anderson (@uthealthsamda) 's Twitter Profile Photo

ABSTRACT SUBMISSIONS DUE AUG. 1! Share your groundbreaking research on liver cancer epidemiology, survivorship, and prevention at the San Antonio Liver Cancer Symposium. Submit your abstract today. We look forward to seeing you on October 9-11! bit.ly/4jJhkFP

ABSTRACT SUBMISSIONS DUE AUG. 1! Share your groundbreaking research on liver cancer epidemiology, survivorship, and prevention at the San Antonio Liver Cancer Symposium. Submit your abstract today. We look forward to seeing you on October 9-11! bit.ly/4jJhkFP
Salud America! (@saludamerica) 's Twitter Profile Photo

SPEAKER ANNOUNCEMENT!šŸ“£ Register today for the 2026 ASCL Conference in San Antonio, Texas and hear from Sukeshi Arora MD. Find more information at latinocancer.com! #ASCL206 #LatinoCancer2026

SPEAKER ANNOUNCEMENT!šŸ“£

Register today for the 2026 ASCL Conference in San Antonio, Texas and hear from <a href="/DrSukeshiArora/">Sukeshi Arora MD</a>. 

Find more information at latinocancer.com!

#ASCL206 #LatinoCancer2026